I hope that Janet Woodcock may have initiated an IG investigation of the lenz trial results, as I learned from jjson that she did with Ocugen. I know Woodcock has her detractors, but I think initiating an IG investigation into her own agency is an example of courageous leadership, and a signal that she will not tolerate undue influence being rendered or received in regards to these trial decisions.
It's that undue influence that has to be eliminated for small independent biotechs like HGEN and IPIX to succeed.